In Silico-Based Screening of Vannamei Shrimp Myosin Protein as a Potential Source of Antihypertensive and Antidiabetic Bioactive Peptides

Erwina Safitri (1) , Septi Nur Rachmawati (1) , Holif Fitriyah (1) , Baiq Dewi Sukma Septiani (1) , Ellanda Rima Ervyanna (1) , Mutiara Vidianinggar (2)
(1) Department of Nutrition, Faculty of Public Health, University of Jember, Jember, Indonesia, Indonesia,
(2) Department of Health Science, Kagawa Nutrition University, Saitama, Japan, Japan

Abstract

Vannamei shrimp (Penaeus vannamei) is an important aquaculture commodity and a potential source of bioactive peptides with diverse health benefits. However, its myosin protein remains underexplored as a source of the peptides. This study aimed to predict antihypertensive and antidiabetic activities of the peptides derived from the shrimp’s myosin using an in silico approach. The myosin sequence was retrieved from the National Center for Biotechnology Information (NCBI) database (GenBank accession number: ROT81-948.1). Basic Local Alignment Search Tool (BLAST) analysis revealed high similarity to myosin heavy chains from several shrimp species, with 93-100% query coverage and 87.67 and 91.43% identity values. Enzymatic hydrolysis was simulated using Bioactive Peptides Database (BIOPEP-UWM) to predict bioactive peptide release. The ficin-bromelain combination released 30 unique bioactive dipeptides, compared with 23 sequences from ficin-papain combination, and produced more dipeptides associated with ACE- and DPP-IV-inhibitory activities. Five dipeptides (EK, DR, EG, IR, and NY) were predicted to exhibit dual ACE- and DPP-IV-inhibitory effects. EA and DL emerged as the most frequent ACE-inhibitory peptides, whereas AL and QL were the most frequent DPP-IV-inhibitory peptides. All identified dipeptides had average molecular weights of <320 Da, consistent with typical bioactive dipeptides. These findings highlight the potential of shrimp myosin hydrolyzed with food-grade proteases as a promising source of bioactive peptides for functional food development.

Full text article

Generated from XML file

References

Acquah, C., Di Stefano, E., & Udenigwe, C. C. (2018). Role of hydrophobicity in food peptide functionality and bioactivity. Journal of Food Bioactives, 4, 88–98. https://doi.org/10.31665/jfb.2018.4164

Agoni, C., Fernández-Díaz, R., Timmons, P. B., Adelfio, A., Gómez, H., & Shields, D. C. (2025). Molecular modelling in bioactive peptide discovery and characterisation. Biomolecules, 15(4), 524. https://doi.org/10.3390/biom15040524

Ahmed, T., Sun, X., & Udenigwe, C. C. (2022). Role of structural properties of bioactive peptides in their stability during simulated gastrointestinal digestion: A systematic review. Trends in Food Science & Technology, 120, 265–273. https://doi.org/10.1016/j.tifs.2022.01.008

Arámburo-Gálvez, J. G., Tinoco-Narez-Gil, R., Mora-Melgem, J. A., Sánchez-Cárdenas, C. A., Gracia-Valenzuela, M. H., Flores-Mendoza, L. K., Figueroa-Salcido, O. G., & Ontiveros, N. (2024). In silico hydrolysis of lupin (Lupinus angustifolius L.) conglutins with plant proteases releases antihypertensive and antidiabetic peptides that are bioavailable, non-toxic, and gastrointestinal digestion stable. International Journal of Molecular Sciences, 25(23), 12866. https://doi.org/10.3390/ijms252312866

Bhat, Z. F., Kumar, S., & Bhat, H. F. (2015). Bioactive peptides of animal origin: A review. Journal of Food Science and Technology, 52(9), 5377–5392. https://doi.org/10.1007/s13197-015-1731-5

Carrera-Alvarado, G., Toldrá, F., & Mora, L. (2022). DPP-IV inhibitory peptides GPF, IGL, and GGGW obtained from chicken blood hydrolysates. International Journal of Molecular Sciences, 23(22), 14140. https://doi.org/10.3390/ijms232214140

Chen, H., Chen, Y., Zheng, H., Xiang, X., & Xu, L. (2022). A novel angiotensin-I-converting enzyme inhibitory peptide from oyster: Simulated gastro-intestinal digestion, molecular docking, inhibition kinetics and antihypertensive effects in rats. Frontiers in Nutrition, 9, 981163. https://doi.org/10.3389/fnut.2022.981163

Choe, Y., Leonetti, F., Greenbaum, D. C., Lecaille, F., Bogyo, M., Brömme, D., Ellman, J. A., & Craik, C. S. (2006). Substrate profiling of cysteine proteases using a combinatorial peptide library identifies functionally unique specificities. The Journal of Biological Chemistry, 281(18), 12824–12832. https://doi.org/10.1074/jbc.M513331200

Cunha, S. A., & Pintado, M. E. (2022). Bioactive peptides derived from marine sources: Biological and functional properties. Trends in Food Science & Technology, 119, 348–370. https://doi.org/10.1016/j.tifs.2021.08.017

CunhaNeves, A., Harnedy-Rothwell, P. A., & FitzGerald, R. J. (2022). In vitro angiotensin-converting enzyme and dipeptidyl peptidase-IV inhibitory, and antioxidant activity of blue mussel (Mytilus edulis) byssus collagen hydrolysates. European Food Research and Technology, 248, 1721–1732. https://doi.org/10.1007/s00217-022-04000-3

Du, H., Zhang, T., Liu, J., Ye, Z., Yu, Z., Zhao, W., & Yu, Y. (2026). Membrane phase separation: An emerging biophysical perspective on food-derived bioactive peptides. Journal of Agricultural and Food Chemistry, 74(32), 24879–24897. https://doi.org/10.1021/acs.jafc.6c07756

Gupta, S., Kapoor, P., Chaudhary, K., Gautam, A., Kumar, R., Open Source Drug Discovery Consortium, & Raghava, G. P. S. (2013). In silico approach for predicting toxicity of peptides and proteins. PLOS ONE, 8(9), e73957. https://doi.org/10.1371/journal.pone.0073957

Heissler, S. M., & Sellers, J. R. (2016). Various themes of myosin regulation. Journal of Molecular Biology, 428(9), 1927–1946. https://doi.org/10.1016/j.jmb.2016.01.022

Hossain, M. A., Nguyen, T. H., & Kim, S.-K. (2020). Isolation and characterization of bioactive peptides from sea cucumber (Cucumaria frondosa) protein hydrolysates. Marine Drugs, 18(2), 94. https://doi.org/10.3390/md18020094

Ichim, N., Marín, F., & Orenes-Piñero, E. (2024). Potential impact of bioactive peptides from foods in the treatment of hypertension. Molecular Nutrition & Food Research, 68(14), e2400084. https://doi.org/10.1002/mnfr.202400084

Iwaniak, A., Minkiewicz, P., & Darewicz, M. (2024). BIOPEP-UWM database — present and future. Current Opinion in Food Science, 55, 101108. https://doi.org/10.1016/j.cofs.2023.101108

Kadam, S. U., Tiwari, B. K., Álvarez, C., & O’Donnell, C. P. (2015). Ultrasound applications for the extraction, identification and delivery of food proteins and bioactive peptides. Trends in Food Science & Technology, 46(1), 60–67. https://doi.org/10.1016/j.tifs.2015.07.012

Koyama, H., Akolkar, D. B., Piyapattanakorn, S., & Watabe, S. (2012). Cloning, expression, and localization of two types of fast skeletal myosin heavy chain genes from black tiger and Pacific white shrimps. Journal of Experimental Zoology Part A: Ecological Genetics and Physiology, 317(10), 608–621. https://doi.org/10.1002/jez.1752

Liang, Q., Zhou, W., Peng, S., Liang, Z., Liu, Z., Wang, L., Mukhtar, H., & Mou, H. (2025). Exploration of ACE inhibitory peptides from sea cucumber viscera with DPP-IV inhibitory activity: Virtual screening, characterization, and potential mechanism investigation. International Journal of Biological Macromolecules, 311(Pt 3), 143843. https://doi.org/10.1016/j.ijbiomac.2025.143843

Matkawala, F., Nighojkar, S., & Nighojkar, A. (2022). Next-generation nutraceuticals: Bioactive peptides from plant proteases. BioTechnologia, 103(4), 397–408. https://doi.org/10.5114/bta.2022.120708

Minkiewicz, P., Iwaniak, A., & Darewicz, M. (2019). BIOPEP-UWM database of bioactive peptides: Current opportunities. International Journal of Molecular Sciences, 20(23), 5978. https://doi.org/10.3390/ijms20235978

Minkiewicz, P., Iwaniak, A., & Darewicz, M. (2022). BIOPEP-UWM Virtual—A novel database of food-derived peptides with in silico-predicted biological activity. Applied Sciences, 12(14), 7204. https://doi.org/10.3390/app12147204

Morellón-Sterling, R., El-Siar, H., Tavano, O. L., Berenguer-Murcia, Á., & Fernández-Lafuente, R. (2020). Ficin: A protease extract with relevance in biotechnology and biocatalysis. International Journal of Biological Macromolecules, 162, 394–404. https://doi.org/10.1016/j.ijbiomac.2020.06.144

Moreno-Mariscal, C., Carrera-Alvarado, G., Mora, L., & Toldrá, F. (2025). Neprilysin (NEP) and angiotensin-converting enzyme-I (ACE-I) inhibitory dipeptides from chicken carcass hydrolysates. LWT, 221, 117591. https://doi.org/10.1016/j.lwt.2025.117591

Neves, A. C., Harnedy, P. A., O’Keeffe, M. B., Alashi, A. M., Aluko, R. E., & FitzGerald, R. J. (2017). Peptide identification in a salmon gelatin hydrolysate with antihypertensive, dipeptidyl peptidase IV inhibitory and antioxidant activities. Food Research International, 100(1), 112–120. https://doi.org/10.1016/j.foodres.2017.06.065

Patil, P. J., Usman, M., Zhang, C., Mehmood, A., Zhou, M., Teng, C., & Li, X. (2022). An updated review on food-derived bioactive peptides: Focus on the regulatory requirements, safety, and bioavailability. Comprehensive Reviews in Food Science and Food Safety, 21(2), 1732–1776. https://doi.org/10.1111/1541-4337.12911

Pearman, N. A., Morris, G. A., & Smith, A. M. (2025). Angiotensin-converting enzyme (ACE)-inhibitor activity of novel peptides derived from porcine liver and placenta. Molecules, 30(3), 754. https://doi.org/10.3390/molecules30030754

Ramlal, A., Nautiyal, A., Baweja, P., Kumar, V., Mehta, S., Mahto, R. K., Tripathi, S., Shanmugam, A., Mallikarjuna, B. P., Raman, P., Lal, S. K., Raju, D., & Rajendran, A. (2022). Angiotensin-converting enzyme inhibitory peptides and isoflavonoids from soybean [Glycine max (L.) Merr.]. Frontiers in Nutrition, 9, 1068388. https://doi.org/10.3389/fnut.2022.1068388

Rivero-Pino, F., Millan-Linares, M. C., & Montserrat-De-La-Paz, S. (2023). Strengths and limitations of in silico tools to assess physicochemical properties, bioactivity, and bioavailability of food-derived peptides. Trends in Food Science & Technology, 138, 433–440. https://doi.org/10.1016/j.tifs.2023.06.023

Sánchez, A., & Vázquez, A. (2017). Bioactive peptides: A review. Food Quality and Safety, 1(1), 29–46. https://doi.org/10.1093/fqsafe/fyx006

Sun, X., Acquah, C., Aluko, R. E., & Udenigwe, C. C. (2020). Considering food matrix and gastrointestinal effects in enhancing bioactive peptide absorption and bioavailability. Journal of Functional Foods, 64, 103680. https://doi.org/10.1016/j.jff.2019.103680

Tacias-Pascacio, V. G., Castañeda-Valbuena, D., Tavano, O. L., Berenguer-Murcia, Á., Torrestiana-Sánchez, B., & Fernández-Lafuente, R. (2023). Peptides with biological and technofunctional properties produced by bromelain hydrolysis of proteins from different sources: A review. International Journal of Biological Macromolecules, 253(Pt 5), 127244. https://doi.org/10.1016/j.ijbiomac.2023.127244

Takahashi, Y., Kamata, A., & Konishi, T. (2021). Dipeptidyl peptidase-IV inhibitory peptides derived from salmon milt and their effects on postprandial blood glucose level. Fisheries Science, 87(5), 619–626. https://doi.org/10.1007/s12562-021-01530-9

Venetikidou, M., Lykartsi, E., Adamantidi, T., Prokopiou, V., Ofrydopoulou, A., Letsiou, S., & Tsoupras, A. (2025). Proteolytic enzyme activities of bromelain, ficin, and papain from fruit by-products and potential applications in sustainable and functional cosmetics for skincare. Applied Sciences, 15(5), 2637. https://doi.org/10.3390/app15052637

Zaky, A. A., Simal-Gandara, J., Eun, J.-B., Shim, J.-H., & Abd El-Aty, A. M. (2022). Bioactivities, applications, safety, and health benefits of bioactive peptides from food and by-products: A review. Frontiers in Nutrition, 8, 815640. https://doi.org/10.3389/fnut.2021.815640

Zhang, S., Li, Z., Feng, Y., Yu, S., Li, Z., Zhang, D., & Wang, C. (2023). DPP-IV inhibitory peptides from coix seed prolamins: Release, identification, and analysis of the interaction between key residues and enzyme domains. Journal of Agricultural and Food Chemistry, 71(40), 14575–14592. https://doi.org/10.1021/acs.jafc.3c02733

Zhang, W., Abubaker, M. A., Li, Z., He, Y., Shu, Q., Li, L., & Liu, Y. (2025). Bioactive peptides with antioxidant and ACE inhibitory properties in goat milk protein hydrolysates: Peptidomics and molecular docking study. International Journal of Biological Macromolecules, 299, 140286. https://doi.org/10.1016/j.ijbiomac.2025.140286

Authors

Erwina Safitri
erwina.safitri@unej.ac.id (Primary Contact)
Septi Nur Rachmawati
Holif Fitriyah
Baiq Dewi Sukma Septiani
Ellanda Rima Ervyanna
Mutiara Vidianinggar
Safitri, E., Rachmawati, S. N., Fitriyah, H., Septiani, B. D. S., Rima Ervyanna, E. ., & Vidianinggar, M. (2026). In Silico-Based Screening of Vannamei Shrimp Myosin Protein as a Potential Source of Antihypertensive and Antidiabetic Bioactive Peptides. Jurnal Teknologi Dan Industri Pangan, 37(3), 258-270. https://doi.org/10.6066/jtip.2026.37.3.258

Article Details

How to Cite

Safitri, E., Rachmawati, S. N., Fitriyah, H., Septiani, B. D. S., Rima Ervyanna, E. ., & Vidianinggar, M. (2026). In Silico-Based Screening of Vannamei Shrimp Myosin Protein as a Potential Source of Antihypertensive and Antidiabetic Bioactive Peptides. Jurnal Teknologi Dan Industri Pangan, 37(3), 258-270. https://doi.org/10.6066/jtip.2026.37.3.258